This map shows the geographic impact of M. Caplin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Caplin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Caplin more than expected).
This network shows the impact of papers produced by M. Caplin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Caplin. The network helps show where M. Caplin may publish in the future.
Co-authorship network of co-authors of M. Caplin
This figure shows the co-authorship network connecting the top 25 collaborators of M. Caplin.
A scholar is included among the top collaborators of M. Caplin based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with M. Caplin. M. Caplin is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
All Works
18 of 18 papers shown
1.
Strosberg, Jonathan, et al.. (2020). Impact of Baseline Liver Tumor Burden, Alkaline Phosphatase (ALP) Elevation, and Target Size Lesion on Therapeutic Effect of 177LU-DOTATATE Treatment: Analysis of Progression Free Survival, and Safety in NETTER-1 Study. Pancreas. 49(3). 489.1 indexed citations
Pavel, Marianne, Marta Benavent, M. Caplin, et al.. (2017). Efficacy and Safety Results of Telotristat Ethyl in Patients With Carcinoid Syndrome During the Double-blind Treatment Period of the TELECAST Phase 3 Clinical Trial. Pancreas. 46(3). 434–435.5 indexed citations
4.
Strosberg, Jonathan, Edward M. Wolin, Beth Chasen, et al.. (2016). NETTER-1 Phase III in Patients With Midgut Neuroendocrine Tumors Treated With 177Lu-DOTATATE: Efficacy and Safety Results.. Neuroendocrinology. 103(5 Suppl 7). 629–629.19 indexed citations
5.
Rindi, Guido, Andrea Frilling, IM Modlin, et al.. (2015). Recommendations for management of patients with neuroendocrine liver metastases. Working Group on Neuroendocrine Liver Metastases.. 8–21.14 indexed citations
Christ, Emanuel, Flavio Forrer, Damian Wild, et al.. (2012). Glucagon-like peptide 1 receptor (GLP-1R) imaging for the preoperative localization of benign insulinomas in 30 patients. 15th International & 14th European Congress of Endocrinology. 29.2 indexed citations
8.
Desai, Kalpna, Mohid S. Khan, Christos Toumpanakis, & M. Caplin. (2009). Management of gastroentero-pancreatic neuroendocrine tumors (GEP-NETs).. PubMed. 55(4). 425–43.5 indexed citations
Caplin, M.. (1986). Early mobilization of uncomplicated myocardial infarct patients.. PubMed. 13(2). 36–40.2 indexed citations
18.
Caplin, M.. (1984). Restriction of cold fluids in myocardial infarction patients: myth or fact?. PubMed. 11(1). 42–5.1 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.